3D-written model improves understanding of cancer

Purdue researchers, led by Luis Solorio, have developed a 3D-written model that created a lifelike cancer environment to better predict how drugs interact with metastasized cells. Findings were published in Advanced Materials.

Solorio, an assistant professor of biomedical engineering, and a team of researchers proposed 3D writing instead of 3D printing in developing a more lifelike cancer environment. The 3D jet-writer produces polymer microtissues as they are shaped in the body, but on a smaller scale, to print an environment with pores large enough for cells to enter the polymer structure. The structure then forms a scaffold that facilitates cell activity as in the body.

So far, researchers have used the 3D jet-writer device to create a structure capable of drawing in cancer cells in mice where cancer would not normally develop, showing the device's ability to create a cancer environment.

"Ideally, we could use our system as an unbiased drug screening platform where we could screen thousands of compounds, hopefully get data within a week, and get it back to a clinician so that it's all within a relevant time frame," Solorio said.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.